DK427281A - Fremgangsmaade til fremstilling af terapeutiske praeparater - Google Patents

Fremgangsmaade til fremstilling af terapeutiske praeparater

Info

Publication number
DK427281A
DK427281A DK427281A DK427281A DK427281A DK 427281 A DK427281 A DK 427281A DK 427281 A DK427281 A DK 427281A DK 427281 A DK427281 A DK 427281A DK 427281 A DK427281 A DK 427281A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
therapeutic preparations
preparations
therapeutic
Prior art date
Application number
DK427281A
Other languages
English (en)
Inventor
T J Andary
L R Berkebile
W R Thomas
D C Tse
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/116,186 external-priority patent/US4287180A/en
Priority claimed from US06/116,187 external-priority patent/US4286056A/en
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of DK427281A publication Critical patent/DK427281A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK427281A 1980-01-28 1981-09-25 Fremgangsmaade til fremstilling af terapeutiske praeparater DK427281A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/116,186 US4287180A (en) 1980-01-28 1980-01-28 Method for treating blood clotting factor inhibitors
US06/116,187 US4286056A (en) 1980-01-28 1980-01-28 Method for making therapeutic enzyme compositions
PCT/US1981/000003 WO1981002105A1 (en) 1980-01-28 1981-01-02 Therapeutic compositions & methods for manufacture and use

Publications (1)

Publication Number Publication Date
DK427281A true DK427281A (da) 1981-09-25

Family

ID=26813964

Family Applications (1)

Application Number Title Priority Date Filing Date
DK427281A DK427281A (da) 1980-01-28 1981-09-25 Fremgangsmaade til fremstilling af terapeutiske praeparater

Country Status (7)

Country Link
EP (1) EP0044343B1 (da)
JP (5) JPH0686385B2 (da)
CA (1) CA1176563A (da)
DE (1) DE3165600D1 (da)
DK (1) DK427281A (da)
IT (1) IT1141963B (da)
WO (1) WO1981002105A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
EP0225160B1 (en) * 1985-11-26 1991-08-21 Novo Nordisk A/S Compositions and methods for the treatment of bleeding disorders
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
AUPN436995A0 (en) * 1995-07-24 1995-08-17 Csl Limited Method for the production of thrombin
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
BR9807936A (pt) * 1997-04-08 2000-02-22 Baxter Ag Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação
AT407484B (de) 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
JP4676585B2 (ja) 1999-12-24 2011-04-27 一般財団法人化学及血清療法研究所 血液凝固異常に基づく疾患の治療・予防用医薬組成物
CA2436807A1 (en) * 2001-02-05 2002-08-15 Novo Nordisk Health Care Ag Combined use of factor vii polypeptides and factor viii polypeptides
AU2003246448A1 (en) 2002-07-23 2004-02-16 Bio-Products And Bio-Engineering Aktiengesellschaft Pharmaceutically active substance preparations and drugs that are capable of generating thrombin and/or that contain thrombin
RS20050051A (sr) 2002-07-23 2007-06-04 Bio-Products & Bio Engineering Ag., Farmaceutski aktivni sastojak preparata i medikamenata koji sadrže trombin ili imaju mogućnost stvaranja trombina
JP2007055899A (ja) * 2003-10-27 2007-03-08 Chemo Sero Therapeut Res Inst 血液凝固第ｘ因子を主剤とする血液凝固異常に基づく疾患の治療・予防用医薬組成物
BR112013008034A2 (pt) * 2010-10-06 2016-06-14 Medimmune Ltd método para normalizar hemeostase comprometida
RU2559576C1 (ru) * 2014-06-09 2015-08-10 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения вирусбезопасного полного протромбинового комплекса

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA920947A (en) * 1968-10-02 1973-02-13 Y. C. Hew Howard Prothrombin complex
US3717708A (en) * 1968-10-24 1973-02-20 Cutter Lab Blood coagulation complex
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
US4170590A (en) * 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
DE2550011C2 (de) * 1975-11-07 1982-11-25 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines antihämophilen Mittels
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
JPH0686385A (ja) * 1992-08-31 1994-03-25 Matsushita Electric Ind Co Ltd 動電型スピーカ

Also Published As

Publication number Publication date
DE3165600D1 (en) 1984-09-27
IT1141963B (it) 1986-10-08
JPH07145074A (ja) 1995-06-06
JPS57500382A (da) 1982-03-04
JPH0686385B2 (ja) 1994-11-02
JPH07145072A (ja) 1995-06-06
JPH07145075A (ja) 1995-06-06
EP0044343A4 (en) 1982-06-10
CA1176563A (en) 1984-10-23
WO1981002105A1 (en) 1981-08-06
EP0044343A1 (en) 1982-01-27
EP0044343B1 (en) 1984-08-22
JPH07145073A (ja) 1995-06-06

Similar Documents

Publication Publication Date Title
DK155172C (da) Fremgangsmaade til fremstilling af liposomholdige farmaceutiske praeparater
DK460283A (da) Fremgangsmaade til fremstilling af topiske farmaceutiske praeparater
DK534481A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK99781A (da) Fremgangsmaade til fremstilling af carboxtyrilderivater
DK2281A (da) Fremgangsmaade til fremstilling af tiazolinderivater
DK300981A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK161581A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK100281A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK427281A (da) Fremgangsmaade til fremstilling af terapeutiske praeparater
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
DK150986C (da) Fremgangsmaade til fremstilling af azopigmentpraeparater
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK564781A (da) Fremgangsmaade til fremstilling af pyrazoloindazolderivater
DK172181A (da) Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater
DK554581A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK364481A (da) Fremgangsmaade til fremstilling af caprylolactamer
DK565281A (da) Fremgangsmaade til fremstilling af quinolon-derivater
DK296281A (da) Fremgangsmaade til fremstilling af aminocyklopentanonamider
DK85281A (da) Fremgangsmaade til fremstilling af phenoxyderivater
DK424781A (da) Fremgangsmaade til fremstilling af quinolonderivater
DK448981A (da) Fremgangsmaade til fremstilling af 4-chinolinmethanderivater
DK579181A (da) Fremgangsmaade til fremstilling af diarylthiophener
DK47681A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK551481A (da) Fremgangsmaade til fremstilling af triazolderivater
DK228381A (da) Fremgangsmaade til fremstilling af antidiarretiske farmaceutiske praeparater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment